BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24069324)

  • 1. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
    Wang SS; Purdue MP; Cerhan JR; Zheng T; Menashe I; Armstrong BK; Lan Q; Hartge P; Kricker A; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Grulich A; Leaderer BP; Davis S; Cozen W; Yeager M; Chanock SJ; Chatterjee N; Rothman N
    PLoS One; 2009; 4(4):e5360. PubMed ID: 19390683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma.
    Wang SS; Menashe I; Cerhan JR; Cozen W; Severson RK; Davis S; Hutchinson A; Rothman N; Chanock SJ; Bernstein L; Hartge P; Morton LM
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):42-9. PubMed ID: 21148756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.
    Lim U; Kocarnik JM; Bush WS; Matise TC; Caberto C; Park SL; Carlson CS; Deelman E; Duggan D; Fesinmeyer M; Haiman CA; Henderson BE; Hindorff LA; Kolonel LN; Peters U; Stram DO; Tiirikainen M; Wilkens LR; Wu C; Kooperberg C; Le Marchand L
    PLoS One; 2014; 9(3):e89791. PubMed ID: 24598796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
    Skibola CF; Bracci PM; Halperin E; Nieters A; Hubbard A; Paynter RA; Skibola DR; Agana L; Becker N; Tressler P; Forrest MS; Sankararaman S; Conde L; Holly EA; Smith MT
    PLoS One; 2008 Jun; 3(7):e2816. PubMed ID: 18636124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
    Charbonneau B; Wang AH; Maurer MJ; Asmann YW; Zent CS; Link BK; Ansell SM; Weiner GJ; Ozsan N; Feldman AL; Witzig TE; Cunningham JM; Dogan A; Habermann TM; Slager SL; Novak AJ; Cerhan JR
    Cancer Immunol Immunother; 2013 Sep; 62(9):1475-84. PubMed ID: 23812490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma.
    Gathany AH; Hartge P; Davis S; Cerhan JR; Severson RK; Cozen W; Rothman N; Chanock SJ; Wang SS
    Cancer Causes Control; 2009 Oct; 20(8):1291-302. PubMed ID: 19396635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in integrin genes and lymphoma risk.
    Shen M; Zheng T; Lan Q; Zhang Y; Hosgood HD; Zahm SH; Holford TR; Leaderer B; Yeager M; Yuenger J; Chanock S; Rothman N
    Leuk Res; 2011 Jul; 35(7):968-70. PubMed ID: 21239057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes.
    Machiela MJ; Lan Q; Slager SL; Vermeulen RC; Teras LR; Camp NJ; Cerhan JR; Spinelli JJ; Wang SS; Nieters A; Vijai J; Yeager M; Wang Z; Ghesquières H; McKay J; Conde L; de Bakker PI; Cox DG; Burdett L; Monnereau A; Flowers CR; De Roos AJ; Brooks-Wilson AR; Giles GG; Melbye M; Gu J; Jackson RD; Kane E; Purdue MP; Vajdic CM; Albanes D; Kelly RS; Zucca M; Bertrand KA; Zeleniuch-Jacquotte A; Lawrence C; Hutchinson A; Zhi D; Habermann TM; Link BK; Novak AJ; Dogan A; Asmann YW; Liebow M; Thompson CA; Ansell SM; Witzig TE; Tilly H; Haioun C; Molina TJ; Hjalgrim H; Glimelius B; Adami HO; Roos G; Bracci PM; Riby J; Smith MT; Holly EA; Cozen W; Hartge P; Morton LM; Severson RK; Tinker LF; North KE; Becker N; Benavente Y; Boffetta P; Brennan P; Foretova L; Maynadie M; Staines A; Lightfoot T; Crouch S; Smith A; Roman E; Diver WR; Offit K; Zelenetz A; Klein RJ; Villano DJ; Zheng T; Zhang Y; Holford TR; Turner J; Southey MC; Clavel J; Virtamo J; Weinstein S; Riboli E; Vineis P; Kaaks R; Boeing H; Tjønneland A; Angelucci E; Di Lollo S; Rais M; De Vivo I; Giovannucci E; Kraft P; Huang J; Ma B; Ye Y; Chiu BC; Liang L; Park JH; Chung CC; Weisenburger DD; Fraumeni JF; Salles G; Glenn M; Cannon-Albright L; Curtin K; Wu X; Smedby KE; de Sanjose S; Skibola CF; Berndt SI; Birmann BM; Chanock SJ; Rothman N
    Hum Mol Genet; 2016 Apr; 25(8):1663-76. PubMed ID: 27008888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma.
    Colt JS; Rothman N; Severson RK; Hartge P; Cerhan JR; Chatterjee N; Cozen W; Morton LM; De Roos AJ; Davis S; Chanock S; Wang SS
    Blood; 2009 Feb; 113(9):1899-905. PubMed ID: 19066394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study.
    Wadé NB; Chang CM; Conti D; Millstein J; Skibola C; Nieters A; Wang SS; De Sanjose S; Kane E; Spinelli JJ; Bracci P; Zhang Y; Slager S; Wang J; Hjalgrim H; Smedby KE; Brown EE; Jarrett RF; Cozen W;
    Cancer Causes Control; 2020 May; 31(5):451-462. PubMed ID: 32124188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes.
    Berndt SI; Vijai J; Benavente Y; Camp NJ; Nieters A; Wang Z; Smedby KE; Kleinstern G; Hjalgrim H; Besson C; Skibola CF; Morton LM; Brooks-Wilson AR; Teras LR; Breeze C; Arias J; Adami HO; Albanes D; Anderson KC; Ansell SM; Bassig B; Becker N; Bhatti P; Birmann BM; Boffetta P; Bracci PM; Brennan P; Brown EE; Burdett L; Cannon-Albright LA; Chang ET; Chiu BCH; Chung CC; Clavel J; Cocco P; Colditz G; Conde L; Conti DV; Cox DG; Curtin K; Casabonne D; De Vivo I; Diepstra A; Diver WR; Dogan A; Edlund CK; Foretova L; Fraumeni JF; Gabbas A; Ghesquières H; Giles GG; Glaser S; Glenn M; Glimelius B; Gu J; Habermann TM; Haiman CA; Haioun C; Hofmann JN; Holford TR; Holly EA; Hutchinson A; Izhar A; Jackson RD; Jarrett RF; Kaaks R; Kane E; Kolonel LN; Kong Y; Kraft P; Kricker A; Lake A; Lan Q; Lawrence C; Li D; Liebow M; Link BK; Magnani C; Maynadie M; McKay J; Melbye M; Miligi L; Milne RL; Molina TJ; Monnereau A; Montalvan R; North KE; Novak AJ; Onel K; Purdue MP; Rand KA; Riboli E; Riby J; Roman E; Salles G; Sborov DW; Severson RK; Shanafelt TD; Smith MT; Smith A; Song KW; Song L; Southey MC; Spinelli JJ; Staines A; Stephens D; Sutherland HJ; Tkachuk K; Thompson CA; Tilly H; Tinker LF; Travis RC; Turner J; Vachon CM; Vajdic CM; Van Den Berg A; Van Den Berg DJ; Vermeulen RCH; Vineis P; Wang SS; Weiderpass E; Weiner GJ; Weinstein S; Doo NW; Ye Y; Yeager M; Yu K; Zeleniuch-Jacquotte A; Zhang Y; Zheng T; Ziv E; Sampson J; Chatterjee N; Offit K; Cozen W; Wu X; Cerhan JR; Chanock SJ; Slager SL; Rothman N
    Leukemia; 2022 Dec; 36(12):2835-2844. PubMed ID: 36273105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of LIN28B Gene Polymorphisms (rs221634, rs221635, rs314276, rs9404590, and rs12194974) with Non-Hodgkin Lymphoma Susceptibility and Clinical/Pathological Features.
    Aghighi A; Nakhaee A; Taheri M; Hashemi SM; Bahari G
    Asian Pac J Cancer Prev; 2023 Nov; 24(11):3867-3874. PubMed ID: 38019245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of cancer prognosis data with multiple subtypes using regularized gradient descent.
    Ma S; Zhang Y; Huang J; Huang Y; Lan Q; Rothman N; Zheng T
    Genet Epidemiol; 2012 Dec; 36(8):829-38. PubMed ID: 22851516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma.
    Bretherick KL; Schuetz JM; Morton LM; Purdue MP; Conde L; Gallagher RP; Connors JM; Gascoyne RD; Berry BR; Armstrong B; Kricker A; Vajdic CM; Grulich A; Hjalgrim H; Smedby KE; Skibola CF; Rothman N; Spinelli JJ; Brooks-Wilson AR
    PLoS One; 2013; 8(9):e74619. PubMed ID: 24069324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma.
    Novik KL; Spinelli JJ; Macarthur AC; Shumansky K; Sipahimalani P; Leach S; Lai A; Connors JM; Gascoyne RD; Gallagher RP; Brooks-Wilson AR
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1098-106. PubMed ID: 17548670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants in ATM, H2AFX and MRE11 genes and susceptibility to breast cancer in the polish population.
    Podralska M; Ziółkowska-Suchanek I; Żurawek M; Dzikiewicz-Krawczyk A; Słomski R; Nowak J; Stembalska A; Pesz K; Mosor M
    BMC Cancer; 2018 Apr; 18(1):452. PubMed ID: 29678143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of genetic polymorphisms in the H2AFX distal promoter.
    Bretherick KL; Leach S; Brooks-Wilson AR
    Mutat Res; 2014; 766-767():37-43. PubMed ID: 25847270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in the DNA repair gene, XRCC1 associate with non-Hodgkin lymphoma susceptibility: A systematic review and meta-analysis.
    Li Y; Bai O; Cui J; Li W
    Eur J Med Genet; 2016 Feb; 59(2):91-103. PubMed ID: 26723520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between polymorphic sites in thymidylate synthase gene and risk of non-Hodgkin lymphoma: a systematic review and pooled analysis.
    Zhou JY; Shi R; Yu HL; Zeng Y; Zheng WL; Ma WL
    Leuk Lymphoma; 2012 Oct; 53(10):1953-60. PubMed ID: 22397721
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.